Growing community of inventors

Kyoto, Japan

Norio Ohnishi

Average Co-Inventor Count = 4.05

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 54

Norio OhnishiRinta Ibuki (3 patents)Norio OhnishiSatoshi Ueda (2 patents)Norio OhnishiFumio Shimojo (2 patents)Norio OhnishiOsamu Aoki (2 patents)Norio OhnishiHiroshi Ishikuro (2 patents)Norio OhnishiAtsuo Ohike (2 patents)Norio OhnishiKazuto Okimoto (2 patents)Norio OhnishiTakeo Hirose (1 patent)Norio OhnishiSumihisa Kimura (1 patent)Norio OhnishiMasayuki Yamanaka (1 patent)Norio OhnishiToshihiko Toyoda (1 patent)Norio OhnishiNorio Ohnishi (5 patents)Rinta IbukiRinta Ibuki (10 patents)Satoshi UedaSatoshi Ueda (39 patents)Fumio ShimojoFumio Shimojo (16 patents)Osamu AokiOsamu Aoki (6 patents)Hiroshi IshikuroHiroshi Ishikuro (4 patents)Atsuo OhikeAtsuo Ohike (4 patents)Kazuto OkimotoKazuto Okimoto (2 patents)Takeo HiroseTakeo Hirose (6 patents)Sumihisa KimuraSumihisa Kimura (6 patents)Masayuki YamanakaMasayuki Yamanaka (3 patents)Toshihiko ToyodaToshihiko Toyoda (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Fujisawa Pharmaceutical Company, Ltd. (4 from 940 patents)

2. Astellas Pharma Gmbh (1 from 416 patents)


5 patents:

1. 7094899 - Vitreous form of known bradykinin antagonist

2. 6509468 - Vitreous form of known bradykinin antagonist

3. 6387918 - Pharmaceutical composition

4. 6316473 - Two surfactant-containing medicinal composition

5. 4390694 - Method for preparing stable crystals of salt of Ceftizoxime

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…